Latest news
Loading news…
I-Mab Biopharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Shanghai, China Founded 2016 11-50 employees For Profit
I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
0
Ticker
IMAB
NASDAQ
Patents
45
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- IMAB
- Exchange
- NASDAQ
- IPO date
- Jan 16, 2020
- Raised at IPO
- $104M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 45
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2016
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 89
- HQ
- Shanghai, China
- Region
- Asia-Pacific (APAC)
- Exit date
- Jan 16, 2020
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.9
- Trend (90d)
- -0.2
- Last leadership hire
- Oct 30, 2025
- Last layoff mention
- Jan 29, 2025
Acquisitions by I-Mab Biopharma
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to I-Mab Biopharma
Loading news…
FAQs about I-Mab Biopharma
People who checked this page also checked these
Browse the full Acquirezy directory.